BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18588562)

  • 1. Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').
    Alvarez-Cuesta E; Bousquet J; Canonica WG; Durham S; Malling HJ; Passalacqua G; Valovirta E
    Allergy; 2008 Jul; 63(7):939-40. PubMed ID: 18588562
    [No Abstract]   [Full Text] [Related]  

  • 2. EAACI 'Standards for practical allergen-specific immunotherapy'.
    Madsen F
    Allergy; 2007 Mar; 62(3):332. PubMed ID: 17298352
    [No Abstract]   [Full Text] [Related]  

  • 3. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.
    Calderón MA; Larenas D; Kleine-Tebbe J; Jacobsen L; Passalacqua G; Eng PA; Varga EM; Valovirta E; Moreno C; Malling HJ; Alvarez-Cuesta E; Durham S; Demoly P
    Allergy; 2011 Oct; 66(10):1345-59. PubMed ID: 21707645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standards for practical allergen-specific immunotherapy.
    Alvarez-Cuesta E; Bousquet J; Canonica GW; Durham SR; Malling HJ; Valovirta E;
    Allergy; 2006; 61 Suppl 82():1-20. PubMed ID: 16930249
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural allergen extracts: is there a future in allergy diagnosis and therapy?
    Lehrer SB; Reese G
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):73-8; discussion 79. PubMed ID: 9383893
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparing and mixing allergen vaccines for subcutaneous immunotherapy.
    Nelson HS
    Clin Allergy Immunol; 2008; 21():303-20. PubMed ID: 18828513
    [No Abstract]   [Full Text] [Related]  

  • 8. American Academy of Otolaryngic Allergy endorses the Allergen Immunotherapy Practice Parameter.
    Fass PT
    J Allergy Clin Immunol; 2008 Jan; 121(1):269-70; author reply 270. PubMed ID: 18206516
    [No Abstract]   [Full Text] [Related]  

  • 9. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract]   [Full Text] [Related]  

  • 10. Standardisation of allergens in Europe.
    Sjöholm I
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):107-10. PubMed ID: 9383897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and specific treatment for a global disease: allergen immunotherapy revisited.
    Kowalski ML
    Allergy; 2006 Jul; 61(7):791-5. PubMed ID: 16792575
    [No Abstract]   [Full Text] [Related]  

  • 12. Instructions and consent forms for subcutaneous allergen immunotherapy.
    Cox L; Lockey RF
    Clin Allergy Immunol; 2008; 21():499-525. PubMed ID: 18828526
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergens and allergen immunotherapy. Preface.
    Lockey RF; Ledford DK
    Clin Allergy Immunol; 2008; 21():vii. PubMed ID: 18828494
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental forms of allergen immunotherapy with modified allergens and adjuvants.
    Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F
    Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of allergen-specific immunotherapy in human and veterinary medicine.
    Loewenstein C; Mueller RS
    Vet Dermatol; 2009 Apr; 20(2):84-98. PubMed ID: 19320877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure.
    Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):xiii-xxii. PubMed ID: 16701138
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of allergen extracts.
    Matthiesen F
    Z Hautkr; 1988; 63 Suppl 4():52-4. PubMed ID: 3252626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspiration before immunotherapy injection is required.
    Geller M
    J Allergy Clin Immunol; 2007 Jul; 120(1):220-1; author reply 221. PubMed ID: 17418378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.